NasdaqCM - Delayed Quote • USD
Tonix Pharmaceuticals Holding Corp. (TNXP)
At close: May 28 at 4:00 PM EDT
After hours: May 28 at 7:59 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 2 | 2 |
Avg. Estimate | -0.22 | -0.17 | -0.95 | -0.6 |
Low Estimate | -0.22 | -0.17 | -1.11 | -0.7 |
High Estimate | -0.22 | -0.17 | -0.8 | -0.5 |
Year Ago EPS | -2.68 | -1.83 | -6.85 | -0.95 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 2.8M | 2.95M | 12.03M | 20.15M |
Low Estimate | 2.8M | 2.95M | 12.03M | 20.15M |
High Estimate | 2.8M | 2.95M | 12.03M | 20.15M |
Year Ago Sales | -- | 3.99M | 7.77M | 12.03M |
Sales Growth (year/est) | -- | -26.00% | 54.90% | 67.50% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | -2.75 | -1.49 | -1.64 | -0.39 |
EPS Actual | -2.68 | -1.83 | -0.86 | -0.18 |
Difference | 0.07 | -0.34 | 0.78 | 0.21 |
Surprise % | 2.50% | -22.80% | 47.60% | 53.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.22 | -0.17 | -0.95 | -0.6 |
7 Days Ago | -0.22 | -0.17 | -0.95 | -0.6 |
30 Days Ago | -0.23 | -0.23 | -1.57 | -1.1 |
60 Days Ago | -1.42 | -1.48 | -3.14 | -1.21 |
90 Days Ago | -1.42 | -1.48 | -4.26 | -1.91 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | -- | -- |
Up Last 30 Days | -- | 1 | 1 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | TNXP | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 91.80% | -- | -- | 7.90% |
Next Qtr. | 90.70% | -- | -- | 10.20% |
Current Year | 86.10% | -- | -- | 4.80% |
Next Year | 36.80% | -- | -- | 12.50% |
Next 5 Years (per annum) | -- | -- | -- | 11.27% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Initiated | Dawson James: Buy | 2/28/2024 |
Maintains | Alliance Global Partners: Buy to Buy | 8/1/2023 |
Maintains | Alliance Global Partners: Buy to Buy | 6/2/2023 |
Maintains | Alliance Global Partners: Buy to Buy | 8/31/2021 |
Maintains | Alliance Global Partners: Buy to Buy | 8/11/2021 |
Maintains | Alliance Global Partners: Buy to Buy | 2/25/2021 |
Related Tickers
JAGX Jaguar Health, Inc.
4.0300
-12.96%
NBY NovaBay Pharmaceuticals, Inc.
0.1410
+6.98%
IBIO iBio, Inc.
2.3900
+9.13%
SCPX Scorpius Holdings, Inc.
0.1119
+6.37%
ENSC Ensysce Biosciences, Inc.
0.5750
+0.52%
KTRA Kintara Therapeutics, Inc.
0.1879
+11.85%
OCGN Ocugen, Inc.
1.7100
-2.29%
PXMD PaxMedica, Inc.
0.3400
+8.56%
OGEN Oragenics, Inc.
2.1200
-4.50%
RNAZ TransCode Therapeutics, Inc.
1.9400
+8.38%